NasdaqGS:SRPTBiotechs
Is Sarepta Therapeutics a Bargain After Its Recent 85% Stock Slide in 2025?
Ever wondered if Sarepta Therapeutics might finally be trading at a price that matches its potential? Let’s dig into what the numbers and the story say about its value right now.
The stock has seen a 6.7% jump in the last week. However, this comes after steeper declines of 15.3% over the past month and nearly 85% year-to-date. This makes the current price feel especially intriguing or risky, depending on your outlook.
Recent headlines have centered on Sarepta’s evolving lineup of gene...